What is PatSnap?

5 tried-and-true steps to increase the ROI of your patent portfolio

Intangible assets, such as patents, are essential to a company’s financial performance and CFO’s are increasingly giving patents more importance on a company’s balance sheet.

Read More

5 signs you should scrap your patent

Abandoning patents is necessary for companies that manage large portfolios, with thousands of patents. Some patents aren’t valuable anymore, yet remain hidden in a large portfolio, adding to your yearly renewal fees. According to Manny Schecter, Chief Patent Officer at IBM, abandonments can contribute to, rather than jeopardise the pursuit of high quality in the patent system. Research also suggests that companies with the largest portfolios, like IBM, abandon the most patents.

Read More

Increase revenue and enhance strategy by learning the value of patent valuations

 

Read More

Your R&D might be worth more than you think, thanks to innovation incentives

Most businesses underestimate what they can claim from innovation incentives. According to the Telegraph, 40% of active companies in the UK generate some form of innovation, yet most business owners have no idea that they qualify for R&D tax credits.

Read More

PatSnap shortlisted for Best BI/Big Data Vendor at the V3 Technology Awards

At PatSnap, everything we do is aimed at enabling the innovators of the world to conduct better, faster research, and improve the R&D process from ideation to commercialisation. In order to achieve that, we’ve pulled together some of the brightest minds in technology to create the platform and underlying algorithms that extract and analyse the most important and relevant information from the innovation landscape, and translate it into business intelligence.

Read More

Overcoming the limitations of stage-gate in new product development (NPD)

The Stage-Gate process can be defined as a framework where large innovation programmes are divided into phases (stage). Each phase is preceded by a review session (gate), where ideas are assessed and deemed worthy of further development or not.  

Read More

Enhance your innovation cycle by knowing customers, competitors and collaborators

Research by CEB reveals that the top priority of R&D leaders is to beat competitors to market with big innovations—but 90% of them also believe their pipelines are slow at turning ideas into successful products. According to the same research, R&D managers report that one third of their projects are behind schedule. Enhancing the innovation cycle is not just about speed to market, it’s also about ensuring your product is profitable so that R&D resources aren’t wasted.

Read More

UK Government explains how it’s tackling IP crime in latest report

During 2016, over 2 million suspected infringing counterfeit goods were detained by border force. IP crime not only impacts the UK economy but also undermines legitimate businesses who work hard to innovate.

Read More

Imperial College professor outlines key considerations when outsourcing IP management

I had the pleasure of interviewing Ian Harvey, Chairman of the IP Centre Advisory Board of Tsinghua University x-lab and adjunct professor in intellectual property (IP) at Imperial College Business School. Ian has a wealth of experience in IP and and was the former CEO of BTG, where IP management was at the core of their business. IP matters were handled in-house however, in this interview, he tells us what to consider when outsourcing IP.

Read More

PatSnap Insights: Pfizer's Viagra Patent Expires

Viagra, or Sildenafil Citrate, is currently patented by Pfizer in the United States, and the patent is set to expire there in April 2020. The company has already signed an agreement to allow Teva Pharmaceuticals to bring a generic Viagra drug to the US market by the end of 2017, and for such an important drug, the implications for both Pfizer and the wider market are expected to be significant. The original patent can be found here in the PatSnap database: US6469012.

Read More